Recruiting Pulmonary Hypertension Studies in Guangzhou
Evaluate the Safety and Clinical Activity of HH2853
This is an open-label, multicenter, first-in-human phase I/II study which is composed of 3 parts: phase I dose escalation, phase I dose extension and phase II. HH2853 will be administered orally on a ...
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab in participants who did not require "Early Terminat...
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
The purpose of the study is to learn how the study medicine called PF-07868489 is tolerated and acts in healthy adult people and people with pulmonary arterial hypertension (PAH). Part A: An investi...
About Pulmonary Hypertension Clinical Trials in Guangzhou
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 3 pulmonary hypertension clinical trials recruiting participants in Guangzhou, GUANGDONG. These studies are seeking a combined 589 participants. Research is being sponsored by Haihe Biopharma Co., Ltd., Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Guangzhou — FAQ
Are there pulmonary hypertension clinical trials in Guangzhou?
Yes, there are 3 pulmonary hypertension clinical trials currently recruiting in Guangzhou, GUANGDONG. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Guangzhou?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Guangzhou research site will contact you about next steps.
Are clinical trials in Guangzhou free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Guangzhou studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 3 active trials in Guangzhou are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov